Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma
Clinical trial NCT05251662 · UNKNOWN
Trial details
- NCT number
- NCT05251662
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-13
- Primary completion
- 2024-01-13
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.